The question remains whether, in addition to C5a and HGF, other factors that are released in tissues in response to anti-cancer treatment such as certain chemokines [13] or bioactive lipids [3, 4] also increase the release of nucleotides from target cells, but this requires further studies. The gene discussed is HGF; the disease is cancer.